Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06898593 · ClinicalTrials.gov registry record · NA

Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients

A NA study of Anxiety Disorders and Depression Disorders, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
2,448
Enrollment target
6
Study locations

NCT06898593: Recruiting NA study of Anxiety Disorders and Depression Disorders, sponsored by Dartmouth-Hitchcock Medical Center.

NCT06898593 is a NA study of Anxiety Disorders and Depression Disorders that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2,448 participants, above the 1,111-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (120% higher). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06898593, a NA study of Anxiety Disorders and Depression Disorders, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
2,448 participants
Enrollment target
6
Study locations

Study Summary

The goal of this clinical trial is to learn if adding patients' goals and concerns to measurement-based collaborative care can tailor care and provide a more holistic view of treatment, thereby improving engagement in care among adult patients receiving collaborative care. The main questions it aims to answer are: * Does using a clinical decision support system (which includes an enhanced pre-visit questionnaire and patient-level dashboard) improve patient engagement in the collaborative care model? * Does using a clinical decision support system improve patient and clinician satisfaction with care? Researchers will compare the enhanced collaborative care with traditional collaborative care. Patient participants will complete pre-visit questionnaires before their collaborative care appointments. Responses will be viewed by the clinician and/or patient in a visual dashboard inside the electronic health record.

Primary Outcome

The primary outcome measure targeted is increased Collaborative Care Model (CoCM) engagement as measured by the proportion of CoCM patients with 2 or more Patient Health Questionnaire (PHQ-9)/Generalized Anxiety Disorder (GAD-7) assessments completed.

Interventions

  • BEHAVIORAL Collaborative care model with clinical decision support system
  • BEHAVIORAL Collaborative care model

Study Locations (6)

New Hampshire

  • Dartmouth Hitchcock Concord Family Medicine - Concord
  • Dartmouth Hitchcock Medical Center - Lebanon
  • Dartmouth-Hitchcock Heater Road Internal Medicine - Lebanon
  • Dartmouth Hitchcock Manchester Family Practice - Manchester
  • Dartmouth Hitchcock Nashua Family Practice - Nashua
  • Dartmouth Hitchcock Nashua General Internal Medicine - Nashua

Trial Details

FieldValue
Enrollment Target 2,448 participants
Start Date 2025-04-02
Est. Completion 2027-06-30
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What NCT06898593 shows while recruiting

NCT06898593 is an interventional study that assigns participants to a tested intervention. Its 2,448 participants enrollment target places it among the larger protocols in the corpus, above the 1,111-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (120% higher).

The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Collaborative care model with clinical decision support system is the first listed.

NCT06898593 lists 6 locations in 1 state (New Hampshire).

Frequently Asked Questions

What is clinical trial NCT06898593 about?

NCT06898593 is a clinical study titled "Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients". The goal of this clinical trial is to learn if adding patients' goals and concerns to measurement-based collaborative care can tailor care and provide a more holistic view of treatment, thereby improving engagement in care among adult patients receiving collaborative care. The main questions it aims...

What is the current status of trial NCT06898593?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,448 participants. The study started on 2025-04-02. Estimated completion is 2027-06-30.

What conditions does trial NCT06898593 study?

This clinical trial studies the following conditions: Anxiety Disorders, Depression Disorders.

What interventions are being tested in trial NCT06898593?

The interventions under investigation include: Collaborative care model with clinical decision support system (BEHAVIORAL), Collaborative care model (BEHAVIORAL).

Who is sponsoring clinical trial NCT06898593?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06898593 being conducted?

This trial has 6 study locations across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06898593's enrollment target sits among peer trials

2,448 6th of 84 higher than 79 of 84 other Anxiety Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06128304 · 2,436 participants · NA

    ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

  • NCT06676904 · 2,433 participants · NA

    Neonatal Platelet Transfusion Threshold Trial

  • NCT05345951 · 2,425 participants · NA

    Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use

  • NCT05873387 · 2,420 participants

    Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06898593, the US trial registry maintained by the National Library of Medicine. NCT06898593 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.